We're sunsetting PodQuest on 2025-07-28. Thank you for your support!
Export Podcast Subscriptions
cover of episode 💊 AI-Developed Drugs Are Coming: AI-Accelerated Drug Discovery

💊 AI-Developed Drugs Are Coming: AI-Accelerated Drug Discovery

2025/1/24
logo of podcast AI Unraveled: Latest AI News & Trends, GPT, ChatGPT, Gemini, Generative AI, LLMs, Prompting

AI Unraveled: Latest AI News & Trends, GPT, ChatGPT, Gemini, Generative AI, LLMs, Prompting

AI Deep Dive AI Chapters Transcript
People
主持人1
主持人2
Topics
主持人1:人工智能正在彻底改变药物研发领域,它不再是遥不可及的未来,而是正在发生的现实。我们已经看到人工智能设计的药物进入临床试验阶段,这标志着医疗保健领域的一场革命。人工智能能够分析海量数据,识别有前景的药物候选者,并显著提高药物研发的效率,这将有望为许多以前无法治愈的疾病带来新的治疗方法。例如,Isomorphic Labs公司利用AlphaFold技术,正在积极研发针对癌症和神经退行性疾病等重大疾病的药物,并即将开展人体临床试验。Insilico Medicine公司也取得了显著进展,他们的人工智能设计药物已进入临床试验阶段,用于治疗特发性肺纤维化和炎症性肠病,初步结果令人鼓舞。这些进展预示着未来药物研发速度的加快和治疗效果的提升,为患者带来更多希望。 然而,我们也必须认识到,人工智能药物研发也带来了一些伦理方面的考量,例如药物的可及性问题。我们需要确保这些技术进步能够惠及所有人,避免加剧现有的医疗保健不平等。在未来,我们需要更多地关注伦理问题,确保人工智能技术能够以负责任的方式用于药物研发,造福全人类。 主持人2:人工智能在药物研发中的作用如同一位超级研究助理,它能够处理和分析远远超过人类能力范围的海量数据,从而快速识别有前景的药物候选者,并预测哪些分子最有可能对特定疾病有效。这不仅提高了药物研发的速度,更重要的是提高了效率,甚至可能帮助我们攻克以前认为无法治愈的疾病。Isomorphic Labs公司和Insilico Medicine公司分别采用了不同的方法,但都取得了令人瞩目的成就。Isomorphic Labs公司专注于利用AlphaFold技术预测蛋白质结构,而Insilico Medicine公司则采用了一种更全面的方法,在药物研发的各个阶段都使用人工智能技术。这两种方法都证明了人工智能在药物研发中的巨大潜力,未来有望彻底改变药物研发流程,为各种疾病带来新的治疗方案。 然而,我们也必须意识到,这项技术的发展也带来了一些挑战。我们需要认真思考如何确保人工智能在药物研发中的公平使用,避免加剧医疗保健资源分配的不平等。此外,还需要进一步研究人工智能模型的可靠性和可解释性,以确保其预测结果的准确性和可信度。只有在充分考虑伦理和社会影响的前提下,才能确保人工智能技术能够安全有效地应用于药物研发,最终造福全人类。

Deep Dive

Shownotes Transcript

💊 AI-Developed Drugs Are Coming:)

AI-driven platforms like DeepMind, Isomorphic Labs, and Insilico Medicine are accelerating the development of groundbreaking drugs, using machine learning to identify potential treatments faster and more efficiently than traditional methods.

  • Alphabet's subsidiary, Isomorphic Labs, is set to begin trials by the end of the year for drugs developed using artificial intelligence, as stated by a Google executive.
  • Isomorphic Labs, established in 2021, collaborates with Eli Lilly and Novartis to use its AI technology, AlphaFold, for discovering new therapies, targeting diseases like cancer and neurodegeneration.
  • Insilico Medicine, a startup, was the first to send an AI-designed drug to clinical trials in 2023, with positive results reported for its treatment of idiopathic pulmonary fibrosis and inflammatory bowel disease.

What this means: This breakthrough could dramatically reduce the time and cost required for drug discovery, leading to faster treatments for complex diseases and potentially saving countless lives. [Listen)] [2025/01/23)]

🚀 AI Chatbot: Automate Your Business, Reduce Costs, Increase Profit

Imagine a 24/7 virtual assistant that never sleeps, always ready to serve customers with instant, accurate responses. Our AI Chatbot solution helps small businesses and organizations:

  • Automate Key Interactions

  • Free up staff by letting the AI Chatbot handle routine inquiries.

  • Streamline sign-ups, bookings, or scheduling for associations, clinics, gyms, and more.

  • Reduce Operational Costs

  • Save on phone support and call center expenses.

  • Lower your overhead by minimizing repetitive tasks that staff previously handled manually.

  • Increase Profit & Engagement

  • Convert more website visitors into paying customers or active members.

  • Improve brand reputation with fast, accurate, and friendly responses around the clock.

Feel free to explore our AI Chatbot demo). If you’d like to learn more, here’s my calendar link for a chat: Schedule a meeting).